Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02082977
Title A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell and Transformed Follicular Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Age Groups: adult
Covered Countries USA | GBR | FRA

Facility Status City State Zip Country Details
GSK Investigational Site Chicago Illinois 60611 United States Details
GSK Investigational Site New York New York 10021 United States Details
GSK Investigational Site Villejuif cedex 94805 France Details
GSK Investigational Site Sutton Surrey SM2 5PT United Kingdom Details
GSK Investigational Site Southampton SO16 6YD United Kingdom Details
*Shaded cells indicate that there was no data available from for the field